{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T03:49:47Z","timestamp":1794368987817,"version":"4.9.0"},"reference-count":184,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2021,5,19]],"date-time":"2021-05-19T00:00:00Z","timestamp":1621382400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2021,5,19]],"date-time":"2021-05-19T00:00:00Z","timestamp":1621382400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Endocrinol"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1038\/s41574-021-00491-4","type":"journal-article","created":{"date-parts":[[2021,5,19]],"date-time":"2021-05-19T10:02:53Z","timestamp":1621418573000},"page":"421-434","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":71,"title":["Adrenal cortex renewal in health and disease"],"prefix":"10.1038","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4974-5567","authenticated-orcid":false,"given":"Rodanthi","family":"Lyraki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9380-7396","authenticated-orcid":false,"given":"Andreas","family":"Schedl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,5,19]]},"reference":[{"key":"491_CR1","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.mce.2015.01.009","volume":"408","author":"R Bandiera","year":"2015","unstructured":"Bandiera, R., Sacco, S., Vidal, V. P. I., Chaboissier, M. C. & Schedl, A. Steroidogenic organ development and homeostasis: a WT1-centric view. Mol. Cell. Endocrinol. 408, 145\u2013155 (2015).","journal-title":"Mol. Cell. Endocrinol."},{"key":"491_CR2","doi-asserted-by":"publisher","first-page":"4111","DOI":"10.1128\/MCB.00222-06","volume":"26","author":"M Zubair","year":"2006","unstructured":"Zubair, M., Ishihara, S., Oka, S., Okumura, K. & Morohashi, K. Two-step regulation of Ad4BP\/SF-1 gene transcription during fetal adrenal development: initiation by a Hox-Pbx1-Prep1 complex and maintenance via autoregulation by Ad4BP\/SF-1. Mol. Cell. Biol. 26, 4111\u20134121 (2006).","journal-title":"Mol. Cell. Biol."},{"key":"491_CR3","doi-asserted-by":"publisher","first-page":"7030","DOI":"10.1128\/MCB.00900-08","volume":"28","author":"M Zubair","year":"2008","unstructured":"Zubair, M., Parker, K. L. & Morohashi, K. Developmental links between the fetal and adult zones of the adrenal cortex revealed by lineage tracing. Mol. Cell. Biol. 28, 7030\u20137040 (2008).","journal-title":"Mol. Cell. Biol."},{"key":"491_CR4","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.devcel.2013.09.003","volume":"27","author":"R Bandiera","year":"2013","unstructured":"Bandiera, R. et al. WT1 maintains adrenal-gonadal primordium identity and marks a population of AGP-like progenitors within the adrenal gland. Dev. Cell 27, 5\u201318 (2013).","journal-title":"Dev. Cell"},{"key":"491_CR5","doi-asserted-by":"publisher","first-page":"4522","DOI":"10.1242\/dev.092775","volume":"140","author":"MA Wood","year":"2013","unstructured":"Wood, M. A. et al. Fetal adrenal capsular cells serve as progenitor cells for steroidogenic and stromal adrenocortical cell lineages in M. musculus. Development 140, 4522\u20134532 (2013).","journal-title":"Development"},{"key":"491_CR6","first-page":"E298","volume":"288","author":"WC Engeland","year":"2005","unstructured":"Engeland, W. C., Ennen, W. B., Elayaperumal, A., Durand, D. A. & Levay-Young, B. K. Zone-specific cell proliferation during compensatory adrenal growth in rats. Am. J. Physiol. Metab. 288, E298\u2013E306 (2005).","journal-title":"Am. J. Physiol. Metab."},{"key":"491_CR7","doi-asserted-by":"publisher","first-page":"3122","DOI":"10.1210\/endo.143.8.8944","volume":"143","author":"F Beuschlein","year":"2002","unstructured":"Beuschlein, F. et al. Steroidogenic factor-1 is essential for compensatory adrenal growth following unilateral adrenalectomy. Endocrinology 143, 3122\u20133135 (2002).","journal-title":"Endocrinology"},{"key":"491_CR8","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1159\/000123069","volume":"31","author":"MA Holzwarth","year":"1980","unstructured":"Holzwarth, M. A., Shinsako, J. & Dallman, M. F. Adrenal regeneration. Time course, effect of hypothalamic hemi-islands and response to unilateral adrenalectomy. Neuroendocrinology 31, 168\u2013176 (1980).","journal-title":"Neuroendocrinology"},{"key":"491_CR9","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1210\/endo-45-1-42","volume":"45","author":"RO Greep","year":"1949","unstructured":"Greep, R. O. & Deane, H. W. Histological, cytochemical and physiological observations on the regeneration of the rat\u2019s adrenal gland following enucleation. Endocrinology 45, 42\u201356 (1949).","journal-title":"Endocrinology"},{"key":"491_CR10","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.stem.2019.04.012","volume":"25","author":"A Grabek","year":"2019","unstructured":"Grabek, A. et al. The adult adrenal cortex undergoes rapid tissue renewal in a sex-specific manner. Cell Stem Cell 25, 290\u2013296.e2 (2019).","journal-title":"Cell Stem Cell"},{"key":"491_CR11","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.1016\/j.cell.2015.05.026","volume":"161","author":"O Bergmann","year":"2015","unstructured":"Bergmann, O. et al. Dynamics of cell generation and turnover in the human heart. Cell 161, 1566\u20131575 (2015).","journal-title":"Cell"},{"key":"491_CR12","doi-asserted-by":"publisher","first-page":"4374","DOI":"10.1073\/pnas.1217505110","volume":"110","author":"L Magrassi","year":"2013","unstructured":"Magrassi, L., Leto, K. & Rossi, F. Lifespan of neurons is uncoupled from organismal lifespan. Proc. Natl Acad. Sci. USA 110, 4374\u20134379 (2013).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"491_CR13","doi-asserted-by":"publisher","first-page":"2719","DOI":"10.1016\/j.yexcr.2011.07.010","volume":"317","author":"BD Simons","year":"2011","unstructured":"Simons, B. D. & Clevers, H. Stem cell self-renewal in intestinal crypt. Exp. Cell Res. 317, 2719\u20132724 (2011).","journal-title":"Exp. Cell Res."},{"key":"491_CR14","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0081865","volume":"8","author":"SP Chang","year":"2013","unstructured":"Chang, S. P. et al. Cell proliferation, movement and differentiation during maintenance of the adult mouse adrenal cortex. PLoS ONE 8, e81865 (2013).","journal-title":"PLoS ONE"},{"key":"491_CR15","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1101\/gad.317412.118","volume":"33","author":"KJ Basham","year":"2019","unstructured":"Basham, K. J. et al. A ZNRF3-dependent Wnt\/\u03b2-catenin signaling gradient is required for adrenal homeostasis. Genes Dev. 33, 209\u2013220 (2019).","journal-title":"Genes Dev."},{"key":"491_CR16","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/S0304-4165(02)00490-7","volume":"1619","author":"F Mitani","year":"2003","unstructured":"Mitani, F., Mukai, K., Miyamoto, H., Suematsu, M. & Ishimura, Y. The undifferentiated cell zone is a stem cell zone in adult rat adrenal cortex. Biochim. Biophys. Acta 1619, 317\u2013324 (2003).","journal-title":"Biochim. Biophys. Acta"},{"key":"491_CR17","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1677\/joe.0.1110477","volume":"111","author":"G Zajicek","year":"1986","unstructured":"Zajicek, G., Ariel, I. & Arber, N. The streaming adrenal cortex: direct evidence of centripetal migration of adrenocytes by estimation of cell turnover rate. J. Endocrinol. 111, 477\u2013482 (1986).","journal-title":"J. Endocrinol."},{"key":"491_CR18","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1016\/j.devcel.2013.07.016","volume":"26","author":"BD Freedman","year":"2013","unstructured":"Freedman, B. D. et al. Adrenocortical zonation results from lineage conversion of differentiated zona glomerulosa cells. Dev. Cell 26, 666\u2013673 (2013).","journal-title":"Dev. Cell"},{"key":"491_CR19","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/s11154-008-9105-1","volume":"10","author":"A Belgorosky","year":"2009","unstructured":"Belgorosky, A., Baquedano, M. S., Guercio, G. & Rivarola, M. A. Expression of the IGF and the aromatase\/estrogen receptor systems in human adrenal tissues from early infancy to late puberty: implications for the development of adrenarche. Rev. Endocr. Metab. Disord. 10, 51\u201361 (2009).","journal-title":"Rev. Endocr. Metab. Disord."},{"key":"491_CR20","doi-asserted-by":"publisher","first-page":"21185","DOI":"10.1073\/pnas.0909471106","volume":"106","author":"P King","year":"2009","unstructured":"King, P., Paul, A. & Laufer, E. Shh signaling regulates adrenocortical development and identifies progenitors of steroidogenic lineages. Proc. Natl Acad. Sci. USA 106, 21185\u201321190 (2009).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"491_CR21","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1210\/en.2009-0814","volume":"151","author":"C-CJ Huang","year":"2010","unstructured":"Huang, C.-C. J., Miyagawa, S., Matsumaru, D., Parker, K. L. & Yao, H. H.-C. Progenitor cell expansion and organ size of mouse adrenal is regulated by sonic hedgehog. Endocrinology 151, 1119\u20131128 (2010).","journal-title":"Endocrinology"},{"key":"491_CR22","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1210\/en.2017-03061","volume":"159","author":"I Finco","year":"2018","unstructured":"Finco, I., Lerario, A. M. & Hammer, G. D. Sonic hedgehog and WNT signaling promote adrenal gland regeneration in male mice. Endocrinology 159, 579\u2013596 (2018).","journal-title":"Endocrinology"},{"key":"491_CR23","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1210\/me.2014-1060","volume":"28","author":"EM Walczak","year":"2014","unstructured":"Walczak, E. M. et al. Wnt signaling inhibits adrenal steroidogenesis by cell-autonomous and non-cell-autonomous mechanisms. Mol. Endocrinol. 28, 1471\u20131486 (2014).","journal-title":"Mol. Endocrinol."},{"key":"491_CR24","doi-asserted-by":"publisher","first-page":"2349","DOI":"10.1242\/dev.004390","volume":"134","author":"P Val","year":"2007","unstructured":"Val, P., Martinez-Barbera, J. P. & Swain, A. Adrenal development is initiated by Cited2 and Wt1 through modulation of Sf-1 dosage. Development 134, 2349\u20132358 (2007).","journal-title":"Development"},{"key":"491_CR25","doi-asserted-by":"publisher","first-page":"1839","DOI":"10.1101\/gad.220102","volume":"16","author":"D Wilhelm","year":"2002","unstructured":"Wilhelm, D. & Englert, C. The Wilms tumor suppressor WT1 regulates early gonad development by activation of Sf1. Genes Dev. 16, 1839\u20131851 (2002).","journal-title":"Genes Dev."},{"key":"491_CR26","doi-asserted-by":"publisher","first-page":"12997","DOI":"10.1073\/pnas.1814072115","volume":"115","author":"C Steenblock","year":"2018","unstructured":"Steenblock, C. et al. Isolation and characterization of adrenocortical progenitors involved in the adaptation to stress. Proc. Natl Acad. Sci. USA 115, 12997\u201313002 (2018).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"491_CR27","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.mce.2016.09.011","volume":"441","author":"C Steenblock","year":"2017","unstructured":"Steenblock, C. et al. Adrenal cortical and chromaffin stem cells: is there a common progeny related to stress adaptation? Mol. Cell. Endocrinol. 441, 156\u2013163 (2017).","journal-title":"Mol. Cell. Endocrinol."},{"key":"491_CR28","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1002\/dvg.20532","volume":"47","author":"S Ching","year":"2009","unstructured":"Ching, S. & Vilain, E. Targeted disruption of sonic hedgehog in the mouse adrenal leads to adrenocortical hypoplasia. Genesis 47, 628\u2013637 (2009).","journal-title":"Genesis"},{"key":"491_CR29","doi-asserted-by":"publisher","first-page":"3931","DOI":"10.1210\/jc.2002-022001","volume":"88","author":"I Bourdeau","year":"2003","unstructured":"Bourdeau, I. et al. Primary pigmented nodular adrenocortical disease: paradoxical responses of cortisol secretion to dexamethasone occur in vitro and are associated with increased expression of the glucocorticoid receptor. J. Clin. Endocrinol. Metab. 88, 3931\u20133937 (2003).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"491_CR30","doi-asserted-by":"publisher","first-page":"2406","DOI":"10.1210\/jc.2009-0031","volume":"94","author":"E Louiset","year":"2009","unstructured":"Louiset, E. et al. The paradoxical increase in cortisol secretion induced by dexamethasone in primary pigmented nodular adrenocortical disease involves a glucocorticoid receptor-mediated effect of dexamethasone on protein kinase A catalytic subunits. J. Clin. Endocrinol. Metab. 94, 2406\u20132413 (2009).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"491_CR31","doi-asserted-by":"publisher","first-page":"2593","DOI":"10.1242\/dev.021493","volume":"135","author":"AC Kim","year":"2008","unstructured":"Kim, A. C. et al. Targeted disruption of \u03b2-catenin in Sf1-expressing cells impairs development and maintenance of the adrenal cortex. Development 135, 2593\u20132602 (2008).","journal-title":"Development"},{"key":"491_CR32","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms3787","volume":"4","author":"M Zebisch","year":"2013","unstructured":"Zebisch, M. et al. Structural and molecular basis of ZNRF3\/RNF43 transmembrane ubiquitin ligase inhibition by the Wnt agonist R-spondin. Nat. Commun. 4, 2787 (2013).","journal-title":"Nat. Commun."},{"key":"491_CR33","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1038\/nature11019","volume":"485","author":"HX Hao","year":"2012","unstructured":"Hao, H. X. et al. ZNRF3 promotes Wnt receptor turnover in an R-spondin-sensitive manner. Nature 485, 195\u2013202 (2012).","journal-title":"Nature"},{"key":"491_CR34","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1101\/gad.277756.116","volume":"30","author":"V Vidal","year":"2016","unstructured":"Vidal, V. et al. The adrenal capsule is a signaling center controlling cell renewal and zonation through Rspo3. Genes Dev. 30, 1389\u20131394 (2016).","journal-title":"Genes Dev."},{"key":"491_CR35","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1093\/hmg\/ddq029","volume":"19","author":"A Berthon","year":"2010","unstructured":"Berthon, A. et al. Constitutive \u03b2-catenin activation induces adrenal hyperplasia and promotes adrenal cancer development. Hum. Mol. Genet. 19, 1561\u20131576 (2010).","journal-title":"Hum. Mol. Genet."},{"key":"491_CR36","doi-asserted-by":"publisher","first-page":"107524","DOI":"10.1016\/j.celrep.2020.107524","volume":"31","author":"E Pignatti","year":"2020","unstructured":"Pignatti, E. et al. \u03b2-Catenin causes adrenal hyperplasia by blocking zonal transdifferentiation. Cell Rep. 31, 107524 (2020).","journal-title":"Cell Rep."},{"key":"491_CR37","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1093\/hmg\/ddt484","volume":"23","author":"A Berthon","year":"2014","unstructured":"Berthon, A. et al. WNT\/\u03b2-catenin signalling is activated in aldosterone-producing adenomas and controls aldosterone production. Hum. Mol. Genet. 23, 889\u2013905 (2014).","journal-title":"Hum. Mol. Genet."},{"key":"491_CR38","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-15332-7","volume":"11","author":"S Leng","year":"2020","unstructured":"Leng, S. et al. \u03b2-Catenin and FGFR2 regulate postnatal rosette-based adrenocortical morphogenesis. Nat. Commun. 11, 1680 (2020).","journal-title":"Nat. Commun."},{"key":"491_CR39","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.1016\/j.celrep.2015.10.049","volume":"13","author":"AS Rocha","year":"2015","unstructured":"Rocha, A. S. et al. The angiocrine factor Rspondin3 is a key determinant of liver zonation. Cell Rep. 13, 1757\u20131764 (2015).","journal-title":"Cell Rep."},{"key":"491_CR40","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1038\/nature14863","volume":"524","author":"B Wang","year":"2015","unstructured":"Wang, B., Zhao, L., Fish, M., Logan, C. Y. & Nusse, R. Self-renewing diploid Axin2+ cells fuel homeostatic renewal of the liver. Nature 524, 180\u2013185 (2015).","journal-title":"Nature"},{"key":"491_CR41","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1002\/aja.1000790104","volume":"79","author":"HW Deane","year":"1946","unstructured":"Deane, H. W. & Greep, R. O. A morphological and histochemical study of the rat\u2019s adrenal cortex after hypophysectomy, with comments on the liver. Am. J. Anat. 79, 117\u2013145 (1946).","journal-title":"Am. J. Anat."},{"key":"491_CR42","doi-asserted-by":"publisher","first-page":"T135","DOI":"10.1530\/JME-15-0257","volume":"56","author":"N Gallo-Payet","year":"2016","unstructured":"Gallo-Payet, N. 60 Years of POMC: adrenal and extra-adrenal functions of ACTH. J. Mol. Endocrinol. 56, T135\u2013T156 (2016).","journal-title":"J. Mol. Endocrinol."},{"key":"491_CR43","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1530\/JME-11-0011","volume":"46","author":"RJ Gorrigan","year":"2011","unstructured":"Gorrigan, R. J., Guasti, L., King, P., Clark, A. J. & Chan, L. F. Localisation of the melanocortin-2-receptor and its accessory proteins in the developing and adult adrenal gland. J. Mol. Endocrinol. 46, 227\u2013232 (2011).","journal-title":"J. Mol. Endocrinol."},{"key":"491_CR44","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms12751","volume":"7","author":"C Drelon","year":"2016","unstructured":"Drelon, C. et al. PKA inhibits WNT signalling in adrenal cortex zonation and prevents malignant tumour development. Nat. Commun. 7, 12751 (2016).","journal-title":"Nat. Commun."},{"key":"491_CR45","doi-asserted-by":"publisher","first-page":"E12265","DOI":"10.1073\/pnas.1809185115","volume":"115","author":"M Mathieu","year":"2018","unstructured":"Mathieu, M. et al. Steroidogenic differentiation and PKA signaling are programmed by histone methyltransferase EZH2 in the adrenal cortex. Proc. Natl Acad. Sci. USA 115, E12265\u2013E12274 (2018).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"491_CR46","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1126\/science.1227604","volume":"338","author":"K Xu","year":"2012","unstructured":"Xu, K. et al. EZH2 oncogenic activity in castration-resistant prostate cancer cells is polycomb-independent. Science 338, 1465\u20131469 (2012).","journal-title":"Science"},{"key":"491_CR47","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1530\/JOE-12-0022","volume":"214","author":"PJ Hornsby","year":"2012","unstructured":"Hornsby, P. J. Adrenarche: a cell biological perspective. J. Endocrinol. 214, 113\u2013119 (2012).","journal-title":"J. Endocrinol."},{"key":"491_CR48","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.98394","volume":"3","author":"T Dumontet","year":"2018","unstructured":"Dumontet, T. et al. PKA signaling drives reticularis differentiation and sexually dimorphic adrenal cortex renewal. JCI Insight 3, e98394 (2018).","journal-title":"JCI Insight"},{"key":"491_CR49","doi-asserted-by":"publisher","first-page":"91","DOI":"10.3109\/07435809509030424","volume":"21","author":"PE Mcewan","year":"1995","unstructured":"Mcewan, P. E., Lindop, G. B. M. & Kenyon, C. J. In vivo studies of the control of DNA synthesis in the rat adrenal cortex and medulla. Endocr. Res. 21, 91\u2013102 (1995).","journal-title":"Endocr. Res."},{"key":"491_CR50","doi-asserted-by":"publisher","first-page":"E303","DOI":"10.1152\/ajpendo.1999.276.2.E303","volume":"276","author":"PE McEwan","year":"1999","unstructured":"McEwan, P. E., Vinson, G. P. & Kenyon, C. J. Control of adrenal cell proliferation by AT1 receptors in response to angiotensin II and low-sodium diet. Am. J. Physiol. Endocrinol. Metab. 276, E303\u2013E309 (1999).","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"491_CR51","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1210\/en.2013-1999","volume":"155","author":"K Nishimoto","year":"2014","unstructured":"Nishimoto, K., Harris, R. B. S., Rainey, W. E. & Seki, T. Sodium deficiency regulates rat adrenal zona glomerulosa gene expression. Endocrinology 155, 1363\u20131372 (2014).","journal-title":"Endocrinology"},{"key":"491_CR52","doi-asserted-by":"publisher","first-page":"2206","DOI":"10.1210\/endo.132.5.8386614","volume":"132","author":"CD Clyne","year":"1993","unstructured":"Clyne, C. D., Nicol, M. R., Macdonald, S. T., Williams, B. C. & Walker, S. W. Angiotensin II stimulates growth and steroidogenesis in zona fasciculata\/reticularis cells from bovine adrenal cortex via the AT1 receptor subtype. Endocrinology 132, 2206\u20132212 (1993).","journal-title":"Endocrinology"},{"key":"491_CR53","doi-asserted-by":"publisher","first-page":"4721","DOI":"10.1210\/en.2004-0491","volume":"145","author":"AP Coll","year":"2004","unstructured":"Coll, A. P. et al. The effects of proopiomelanocortin deficiency on murine adrenal development and responsiveness to adrenocorticotropin. Endocrinology 145, 4721\u20134727 (2004).","journal-title":"Endocrinology"},{"key":"491_CR54","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.mce.2010.12.006","volume":"336","author":"CR Jefcoate","year":"2011","unstructured":"Jefcoate, C. R., Lee, J., Cherradi, N., Takemori, H. & Duan, H. cAMP stimulation of StAR expression and cholesterol metabolism is modulated by co-expression of labile suppressors of transcription and mRNA turnover. Mol. Cell. Endocrinol. 336, 53\u201362 (2011).","journal-title":"Mol. Cell. Endocrinol."},{"key":"491_CR55","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1677\/JME-10-0006","volume":"45","author":"Y Xing","year":"2010","unstructured":"Xing, Y., Parker, C. R., Edwards, M. & Rainey, W. E. ACTH is a potent regulator of gene expression in human adrenal cells. J. Mol. Endocrinol. 45, 59\u201368 (2010).","journal-title":"J. Mol. Endocrinol."},{"key":"491_CR56","doi-asserted-by":"publisher","first-page":"32875","DOI":"10.1074\/jbc.274.46.32875","volume":"274","author":"AM Lefran\u00e7ois-Martinez","year":"1999","unstructured":"Lefran\u00e7ois-Martinez, A. M. et al. Product of side-chain cleavage of cholesterol, isocaproaldehyde, is an endogenous specific substrate of mouse vas deferens protein, an aldose reductase-like protein in adrenocortical cells. J. Biol. Chem. 274, 32875\u201332880 (1999).","journal-title":"J. Biol. Chem."},{"key":"491_CR57","doi-asserted-by":"publisher","first-page":"4320","DOI":"10.1210\/en.2004-0179","volume":"145","author":"M Thomas","year":"2004","unstructured":"Thomas, M., Keramidas, M., Monchaux, E. & Feige, J.-J. Dual hormonal regulation of endocrine tissue mass and vasculature by adrenocorticotropin in the adrenal cortex. Endocrinology 145, 4320\u20134329 (2004).","journal-title":"Endocrinology"},{"key":"491_CR58","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1038\/ng1501","volume":"37","author":"LA Metherell","year":"2005","unstructured":"Metherell, L. A. et al. Mutations in MRAP, encoding a new interacting partner of the ACTH receptor, cause familial glucocorticoid deficiency type 2. Nat. Genet. 37, 166\u2013170 (2005).","journal-title":"Nat. Genet."},{"key":"491_CR59","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1159\/000342504","volume":"24","author":"E Meimaridou","year":"2013","unstructured":"Meimaridou, E. et al. ACTH resistance: genes and mechanisms. Endocr. Dev. 24, 57\u201366 (2013).","journal-title":"Endocr. Dev."},{"key":"491_CR60","doi-asserted-by":"publisher","first-page":"fj201701274RR","DOI":"10.1096\/fj.201701274RR","volume":"32","author":"TV Novoselova","year":"2018","unstructured":"Novoselova, T. V. et al. MRAP deficiency impairs adrenal progenitor cell differentiation and gland zonation. FASEB J. 32, fj201701274RR (2018).","journal-title":"FASEB J."},{"key":"491_CR61","doi-asserted-by":"publisher","first-page":"18205","DOI":"10.1073\/pnas.0706953104","volume":"104","author":"D Chida","year":"2007","unstructured":"Chida, D. et al. Melanocortin 2 receptor is required for adrenal gland development, steroidogenesis, and neonatal gluconeogenesis. Proc. Natl Acad. Sci. USA 104, 18205\u201318210 (2007).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"491_CR62","doi-asserted-by":"publisher","first-page":"R122","DOI":"10.1530\/EC-19-0190","volume":"8","author":"TV Novoselova","year":"2019","unstructured":"Novoselova, T. V. et al. ACTH signalling and adrenal development: lessons from mouse models. Endocr. Connect. 8, R122\u2013R130 (2019).","journal-title":"Endocr. Connect."},{"key":"491_CR63","doi-asserted-by":"publisher","first-page":"E965","DOI":"10.1152\/ajpendo.00070.2006","volume":"291","author":"YM Ulrich-Lai","year":"2006","unstructured":"Ulrich-Lai, Y. M. et al. Chronic stress induces adrenal hyperplasia and hypertrophy in a subregion-specific manner. Am. J. Physiol. Endocrinol. Metab. 291, E965\u2013E973 (2006).","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"491_CR64","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1677\/joe.0.1160201","volume":"116","author":"FE Estivariz","year":"1988","unstructured":"Estivariz, F. E., Carino, M., Lowry, P. J. & Jackson, S. Further evidence that N-terminal pro-opiomelanocortin peptides are involved in adrenal mitogenesis. J. Endocrinol. 116, 201\u2013206 (1988).","journal-title":"J. Endocrinol."},{"key":"491_CR65","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.mce.2010.12.012","volume":"336","author":"POR de Mendon\u00e7a","year":"2011","unstructured":"de Mendon\u00e7a, P. O. R. & Lotfi, C. F. P. The proliferative effect of synthetic N-POMC1-28 peptides in rat adrenal cortex: a possible role for cyclin E. Mol. Cell. Endocrinol. 336, 156\u2013161 (2011).","journal-title":"Mol. Cell. Endocrinol."},{"key":"491_CR66","doi-asserted-by":"publisher","first-page":"2171","DOI":"10.1210\/jc.2002-021318","volume":"88","author":"M Fassnacht","year":"2003","unstructured":"Fassnacht, M. et al. N-terminal proopiomelanocortin acts as a mitogen in adrenocortical tumor cells and decreases adrenal steroidogenesis. J. Clin. Endocrinol. Metab. 88, 2171\u20132179 (2003).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"491_CR67","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1677\/joe.1.06749","volume":"190","author":"AP Coll","year":"2006","unstructured":"Coll, A. P. et al. Peripheral administration of the N-terminal pro-opiomelanocortin fragment 1\u201328 to Pomc\u2013\/\u2013 mice reduces food intake and weight but does not affect adrenal growth or corticosterone production. J. Endocrinol. 190, 515\u2013525 (2006).","journal-title":"J. Endocrinol."},{"key":"491_CR68","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.mce.2011.10.006","volume":"351","author":"C De Joussineau","year":"2012","unstructured":"De Joussineau, C. et al. The cAMP pathway and the control of adrenocortical development and growth. Mol. Cell. Endocrinol. 351, 28\u201336 (2012).","journal-title":"Mol. Cell. Endocrinol."},{"key":"491_CR69","doi-asserted-by":"publisher","first-page":"2147","DOI":"10.1210\/jc.2002-021362","volume":"88","author":"MCBV Fragoso","year":"2003","unstructured":"Fragoso, M. C. B. V. et al. Cushing\u2019s syndrome secondary to adrenocorticotropin-independent macronodular adrenocortical hyperplasia due to activating mutations of GNAS1 gene. J. Clin. Endocrinol. Metab. 88, 2147\u20132151 (2003).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"491_CR70","doi-asserted-by":"publisher","first-page":"1688","DOI":"10.1056\/NEJM199112123252403","volume":"325","author":"LS Weinstein","year":"1991","unstructured":"Weinstein, L. S. et al. Activating mutations of the stimulatory G protein in the McCune\u2013Albright syndrome. N. Engl. J. Med. 325, 1688\u20131695 (1991).","journal-title":"N. Engl. J. Med."},{"key":"491_CR71","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1172\/JCI127429","volume":"130","author":"MJ Taylor","year":"2020","unstructured":"Taylor, M. J. et al. Chemogenetic activation of adrenocortical Gq signaling causes hyperaldosteronism and disrupts functional zonation. J. Clin. Invest. 130, 83\u201393 (2020).","journal-title":"J. Clin. Invest."},{"key":"491_CR72","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1210\/js.2018-00270","volume":"3","author":"C Suthiworachai","year":"2019","unstructured":"Suthiworachai, C. et al. Identification and functional analysis of six DAX1 mutations in patients with X-linked adrenal hypoplasia congenita. J. Endocr. Soc. 3, 171\u2013180 (2019).","journal-title":"J. Endocr. Soc."},{"key":"491_CR73","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1038\/372635a0","volume":"372","author":"E Zanaria","year":"1994","unstructured":"Zanaria, E. et al. An unusual member of the nuclear hormone receptor superfamily responsible for X-linked adrenal hypoplasia congenita. Nature 372, 635\u2013641 (1994).","journal-title":"Nature"},{"key":"491_CR74","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1038\/372672a0","volume":"372","author":"F Muscatelli","year":"1994","unstructured":"Muscatelli, F. et al. Mutations in the DAX-1 gene give rise to both X-linked adrenal hypoplasia congenita and hypogonadotropic hypogonadism. Nature 372, 672\u2013676 (1994).","journal-title":"Nature"},{"key":"491_CR75","doi-asserted-by":"publisher","DOI":"10.1186\/s12902-020-0500-2","volume":"20","author":"MCC Vargas","year":"2020","unstructured":"Vargas, M. C. C. et al. Spontaneous fertility and variable spectrum of reproductive phenotype in a family with adult-onset X-linked adrenal insufficiency harboring a novel DAX-1\/NR0B1 mutation. BMC Endocr. Disord. 20, 21 (2020).","journal-title":"BMC Endocr. Disord."},{"key":"491_CR76","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.1128\/MCB.17.3.1476","volume":"17","author":"M Ito","year":"1997","unstructured":"Ito, M., Yu, R. & Jameson, J. L. DAX-1 inhibits SF-1-mediated transactivation via a carboxy-terminal domain that is deleted in adrenal hypoplasia congenita. Mol. Cell. Biol. 17, 1476\u20131483 (1997).","journal-title":"Mol. Cell. Biol."},{"key":"491_CR77","doi-asserted-by":"publisher","first-page":"2949","DOI":"10.1128\/MCB.18.5.2949","volume":"18","author":"PA Crawford","year":"1998","unstructured":"Crawford, P. A., Dorn, C., Sadovsky, Y. & Milbrandt, J. Nuclear receptor DAX-1 recruits nuclear receptor corepressor N-CoR to steroidogenic factor 1. Mol. Cell. Biol. 18, 2949\u20132956 (1998).","journal-title":"Mol. Cell. Biol."},{"key":"491_CR78","doi-asserted-by":"crossref","first-page":"3798","DOI":"10.1242\/dev.150516","volume":"144","author":"Y Xing","year":"2017","unstructured":"Xing, Y., Morohashi, K. I., Ingraham, H. A. & Hammer, G. D. Timing of adrenal regression controlled by synergistic interaction between SF1 SUMOylation and Dax1. Development 144, 3798\u20133807 (2017).","journal-title":"Development"},{"key":"491_CR79","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1002\/stem.78","volume":"27","author":"O Khalfallah","year":"2009","unstructured":"Khalfallah, O., Rouleau, M., Barbry, P., Bardoni, B. & Lalli, E. Dax-1 knockdown in mouse embryonic stem cells induces loss of pluripotency and multilineage differentiation. Stem Cell 27, 1529\u20131537 (2009).","journal-title":"Stem Cell"},{"key":"491_CR80","doi-asserted-by":"publisher","first-page":"2711","DOI":"10.1210\/me.2005-0461","volume":"20","author":"BM Gummow","year":"2006","unstructured":"Gummow, B. M., Scheys, J. O., Cancelli, V. R. & Hammer, G. D. Reciprocal regulation of a glucocorticoid receptor-steroidogenic factor-1 transcription complex on the Dax-1 promoter by glucocorticoids and adrenocorticotropic hormone in the adrenal cortex. Mol. Endocrinol. 20, 2711\u20132723 (2006).","journal-title":"Mol. Endocrinol."},{"key":"491_CR81","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1210\/endo.143.2.8658","volume":"143","author":"PS Babu","year":"2002","unstructured":"Babu, P. S. et al. Interaction between Dax-1 and steroidogenic factor-1 in vivo: Increased adrenal responsiveness to ACTH in the absence of Dax-1. Endocrinology 143, 665\u2013673 (2002).","journal-title":"Endocrinology"},{"key":"491_CR82","doi-asserted-by":"publisher","first-page":"3430","DOI":"10.1210\/en.2010-0986","volume":"152","author":"JO Scheys","year":"2011","unstructured":"Scheys, J. O., Heaton, J. H. & Hammer, G. D. Evidence of adrenal failure in aging Dax1-deficient mice. Endocrinology 152, 3430\u20133439 (2011).","journal-title":"Endocrinology"},{"key":"491_CR83","doi-asserted-by":"publisher","first-page":"3738","DOI":"10.1210\/en.2017-00098","volume":"158","author":"A Levasseur","year":"2017","unstructured":"Levasseur, A., St-Jean, G., Paquet, M., Boerboom, D. & Boyer, A. Targeted disruption of YAP and TAZ impairs the maintenance of the adrenal cortex. Endocrinology 158, 3738\u20133753 (2017).","journal-title":"Endocrinology"},{"key":"491_CR84","doi-asserted-by":"publisher","first-page":"84634","DOI":"10.18632\/oncotarget.12382","volume":"7","author":"RH Abduch","year":"2016","unstructured":"Abduch, R. H. et al. Unraveling the expression of the oncogene YAP1, a Wnt\/\u03b2-catenin target, in adrenocortical tumors and its association with poor outcome in pediatric patients. Oncotarget 7, 84634\u201384644 (2016).","journal-title":"Oncotarget"},{"key":"491_CR85","doi-asserted-by":"publisher","first-page":"bqaa052","DOI":"10.1210\/endocr\/bqaa052","volume":"161","author":"A M\u00e9nard","year":"2020","unstructured":"M\u00e9nard, A. et al. Targeted disruption of Lats1 and Lats2 in mice impairs adrenal cortex development and alters adrenocortical cell fate. Endocrinology 161, bqaa052 (2020).","journal-title":"Endocrinology"},{"key":"491_CR86","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1182\/blood.V98.3.618","volume":"98","author":"JF Dimartino","year":"2001","unstructured":"Dimartino, J. F. et al. The Hox cofactor and proto-oncogene Pbx1 is required for maintenance of definitive hematopoiesis in the fetal liver. Blood 98, 618\u2013626 (2001).","journal-title":"Blood"},{"key":"491_CR87","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1210\/en.2006-0681","volume":"148","author":"UD Lichtenauer","year":"2007","unstructured":"Lichtenauer, U. D. et al. Pre-B-cell transcription factor 1 and steroidogenic factor 1 synergistically regulate adrenocortical growth and steroidogenesis. Endocrinology 148, 693\u2013704 (2007).","journal-title":"Endocrinology"},{"key":"491_CR88","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1210\/me.2003-0333","volume":"18","author":"ML Bland","year":"2004","unstructured":"Bland, M. L., Fowkes, R. C. & Ingraham, H. A. Differential requirement for steroidogenic factor-1 gene dosage in adrenal development versus endocrine function. Mol. Endocrinol. 18, 941\u2013952 (2004).","journal-title":"Mol. Endocrinol."},{"key":"491_CR89","first-page":"E139","volume":"293","author":"M Bielohuby","year":"2007","unstructured":"Bielohuby, M. et al. Growth analysis of the mouse adrenal gland from weaning to adulthood: time- and gender-dependent alterations of cell size and number in the cortical compartment. Am. J. Physiol. Metab. 293, E139\u2013E146 (2007).","journal-title":"Am. J. Physiol. Metab."},{"key":"491_CR90","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1111\/j.1365-2826.2004.01195.x","volume":"16","author":"JV Seale","year":"2004","unstructured":"Seale, J. V. et al. Gonadectomy reverses the sexually diergic patterns of circadian and stress-induced hypothalamic-pituitary-adrenal axis activity in male and female rats. J. Neuroendocrinol. 16, 516\u2013524 (2004).","journal-title":"J. Neuroendocrinol."},{"key":"491_CR91","doi-asserted-by":"publisher","first-page":"E1010","DOI":"10.1152\/ajpendo.00316.2006","volume":"292","author":"CM Bastida","year":"2007","unstructured":"Bastida, C. M. et al. Sexual dimorphism of ornithine decarboxylase in the mouse adrenal: influence of polyamine deprivation on catecholamine and corticoid levels. Am. J. Physiol. Endocrinol. Metab. 292, E1010\u2013E1017 (2007).","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"491_CR92","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1046\/j.1365-2443.2002.00556.x","volume":"7","author":"T Mukai","year":"2002","unstructured":"Mukai, T. et al. Sexually dimorphic expression of Dax-1 in the adrenal cortex. Genes Cell 7, 717\u2013729 (2002).","journal-title":"Genes Cell"},{"key":"491_CR93","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1210\/en.2006-1100","volume":"148","author":"L Hershkovitz","year":"2007","unstructured":"Hershkovitz, L., Beuschlein, F., Klammer, S., Krup, M. & Weinstein, Y. Adrenal 20\u03b1-hydroxysteroid dehydrogenase in the mouse catabolizes progesterone and 11-deoxycorticosterone and is restricted to the X-zone. Endocrinology 148, 976\u2013988 (2007).","journal-title":"Endocrinology"},{"key":"491_CR94","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1055\/s-0033-1349881","volume":"45","author":"A El Wakil","year":"2013","unstructured":"El Wakil, A., Mari, B., Barhanin, J. & Lalli, E. Genomic analysis of sexual dimorphism of gene expression in the mouse adrenal gland. Horm. Metab. Res. 45, 870\u2013873 (2013).","journal-title":"Horm. Metab. Res."},{"key":"491_CR95","doi-asserted-by":"publisher","first-page":"26","DOI":"10.3389\/fendo.2017.00026","volume":"8","author":"K Jopek","year":"2017","unstructured":"Jopek, K. et al. Transcriptome profile of rat adrenal evoked by gonadectomy and testosterone or estradiol replacement. Front. Endocrinol. 8, 26 (2017).","journal-title":"Front. Endocrinol."},{"key":"491_CR96","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.neuroscience.2016.02.009","volume":"320","author":"MG Pisu","year":"2016","unstructured":"Pisu, M. G. et al. Sex differences in the outcome of juvenile social isolation on HPA axis function in rats. Neuroscience 320, 172\u2013182 (2016).","journal-title":"Neuroscience"},{"key":"491_CR97","doi-asserted-by":"publisher","first-page":"3067","DOI":"10.1210\/en.2003-0064","volume":"144","author":"V Viau","year":"2003","unstructured":"Viau, V., Lee, P., Sampson, J. & Wu, J. A testicular influence on restraint-induced activation of medial parvocellular neurons in the paraventricular nucleus in the male rat. Endocrinology 144, 3067\u20133075 (2003).","journal-title":"Endocrinology"},{"key":"491_CR98","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1002\/cphy.c130054","volume":"4","author":"N Goel","year":"2014","unstructured":"Goel, N., Workman, J. L., Lee, T. T., Innala, L. & Viau, V. Sex differences in the HPA axis. Compr. Physiol. 4, 1121\u20131155 (2014).","journal-title":"Compr. Physiol."},{"key":"491_CR99","doi-asserted-by":"publisher","first-page":"2659","DOI":"10.1210\/endo.137.7.8770883","volume":"137","author":"FM Bentvelsen","year":"1996","unstructured":"Bentvelsen, F. M., Mcphaul, M. J., Wilson, C. M., Wilson, J. D. & George, F. W. Regulation of immunoreactive androgen receptor in the adrenal gland of the adult rat. Endocrinology 137, 2659\u20132663 (1996).","journal-title":"Endocrinology"},{"key":"491_CR100","doi-asserted-by":"publisher","first-page":"3180","DOI":"10.1210\/endo-127-6-3180","volume":"127","author":"M Sar","year":"1990","unstructured":"Sar, M., Lubahn, D. B., French, F. S. & Wilson, E. M. Immunohistochemical localization of the androgen receptor in rat and human tissues. Endocrinology 127, 3180\u20133186 (1990).","journal-title":"Endocrinology"},{"key":"491_CR101","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-46049-3","volume":"9","author":"A-L Gannon","year":"2019","unstructured":"Gannon, A.-L. et al. Androgen receptor signalling in the male adrenal facilitates X-zone regression, cell turnover and protects against adrenal degeneration during ageing. Sci. Rep. 9, 10457 (2019).","journal-title":"Sci. Rep."},{"key":"491_CR102","doi-asserted-by":"publisher","first-page":"4807","DOI":"10.1128\/MCB.02039-06","volume":"27","author":"J Miyamoto","year":"2007","unstructured":"Miyamoto, J. et al. The pituitary function of androgen receptor constitutes a glucocorticoid production circuit. Mol. Cell. Biol. 27, 4807\u20134814 (2007).","journal-title":"Mol. Cell. Biol."},{"key":"491_CR103","doi-asserted-by":"publisher","first-page":"R51","DOI":"10.1530\/JOE-18-0632","volume":"241","author":"C-CJ Huang","year":"2019","unstructured":"Huang, C.-C. J. & Kang, Y. The transient cortical zone in the adrenal gland: the mystery of the adrenal X-zone. J. Endocrinol. 241, R51\u2013R63 (2019).","journal-title":"J. Endocrinol."},{"key":"491_CR104","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1177\/070674379303800807","volume":"38","author":"E Stein","year":"1993","unstructured":"Stein, E., McCrank, E., Schaefer, B. & Goyer, R. Adrenal gland weight and suicide. Can. J. Psychiatry 38, 563\u2013566 (1993).","journal-title":"Can. J. Psychiatry"},{"key":"491_CR105","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1385\/EP:12:1:33","volume":"12","author":"KY Lam","year":"2001","unstructured":"Lam, K. Y., Chan, A. C. L. & Lo, C. Y. Morphological analysis of adrenal glands: a prospective analysis. Endocr. Pathol. 12, 33\u201338 (2001).","journal-title":"Endocr. Pathol."},{"key":"491_CR106","doi-asserted-by":"publisher","first-page":"e200","DOI":"10.1210\/clinem\/dgz214","volume":"105","author":"K Nonaka","year":"2019","unstructured":"Nonaka, K. et al. Correlation between telomere attrition of zona fasciculata and adrenal weight reduction in older men. J. Clin. Endocrinol. Metab. 105, e200\u2013e210 (2019).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"491_CR107","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1055\/s-2007-982518","volume":"39","author":"B Ludescher","year":"2007","unstructured":"Ludescher, B. et al. Gender specific correlations of adrenal gland size and body fat distribution: a whole body MRI study. Horm. Metab. Res. 39, 515\u2013518 (2007).","journal-title":"Horm. Metab. Res."},{"key":"491_CR108","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.coemr.2019.07.008","volume":"8","author":"A Levasseur","year":"2019","unstructured":"Levasseur, A., Dumontet, T. & Martinez, A. Sexual dimorphism in adrenal gland development and tumorigenesis. Curr. Opin. Endocr. Metab. Res. 8, 60\u201365 (2019).","journal-title":"Curr. Opin. Endocr. Metab. Res."},{"key":"491_CR109","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1016\/S0140-6736(14)61375-1","volume":"386","author":"A Lacroix","year":"2015","unstructured":"Lacroix, A., Feelders, R. A., Stratakis, C. A. & Nieman, L. K. Cushing\u2019s syndrome. Lancet 386, 913\u2013927 (2015).","journal-title":"Lancet"},{"key":"491_CR110","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1007\/s00345-012-1011-1","volume":"31","author":"F Audenet","year":"2013","unstructured":"Audenet, F., M\u00e9jean, A., Chartier-Kastler, E. & Roupr\u00eat, M. Adrenal tumours are more predominant in females regardless of their histological subtype: a review. World J. Urol. 31, 1037\u20131043 (2013).","journal-title":"World J. Urol."},{"key":"491_CR111","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1200\/JCO.2004.08.085","volume":"22","author":"E Michalkiewicz","year":"2004","unstructured":"Michalkiewicz, E. et al. Clinical and outcome characteristics of children with adrenocortical tumors: a report from the international pediatric adrenocortical tumor registry. J. Clin. Oncol. 22, 838\u2013845 (2004).","journal-title":"J. Clin. Oncol."},{"key":"491_CR112","doi-asserted-by":"publisher","first-page":"E2238","DOI":"10.1210\/jc.2012-2374","volume":"97","author":"R Sirianni","year":"2012","unstructured":"Sirianni, R. et al. Targeting estrogen receptor-\u03b1 reduces adrenocortical cancer (ACC) cell growth in vitro and in vivo: potential therapeutic role of selective estrogen receptor modulators (SERMs) for ACC treatment. J. Clin. Endocrinol. Metab. 97, E2238\u2013E2250 (2012).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"491_CR113","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1677\/joe.0.1590373","volume":"159","author":"R Rossi","year":"1998","unstructured":"Rossi, R. et al. Evidence for androgen receptor gene expression and growth inhibitory effect of dihydrotestosterone on human adrenocortical cells. J. Endocrinol. 159, 373\u2013380 (1998).","journal-title":"J. Endocrinol."},{"key":"491_CR114","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1038\/s41574-019-0221-7","volume":"15","author":"J Crona","year":"2019","unstructured":"Crona, J. & Beuschlein, F. Adrenocortical carcinoma \u2014 towards genomics guided clinical care. Nat. Rev. Endocrinol. 15, 548\u2013560 (2019).","journal-title":"Nat. Rev. Endocrinol."},{"key":"491_CR115","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1210\/er.2013-1029","volume":"35","author":"T Else","year":"2014","unstructured":"Else, T. et al. Adrenocortical carcinoma. Endocr. Rev. 35, 282\u2013326 (2014).","journal-title":"Endocr. Rev."},{"key":"491_CR116","doi-asserted-by":"publisher","first-page":"5282","DOI":"10.1038\/s41388-020-1358-5","volume":"39","author":"KS Borges","year":"2020","unstructured":"Borges, K. S. et al. Wnt\/\u03b2-catenin activation cooperates with loss of p53 to cause adrenocortical carcinoma in mice. Oncogene 39, 5282\u20135291 (2020).","journal-title":"Oncogene"},{"key":"491_CR117","doi-asserted-by":"publisher","first-page":"105414","DOI":"10.1016\/j.jsbmb.2019.105414","volume":"193","author":"A Jouinot","year":"2019","unstructured":"Jouinot, A., Armignacco, R. & Assi\u00e9, G. Genomics of benign adrenocortical tumors. J. Steroid Biochem. Mol. Biol. 193, 105414 (2019).","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"491_CR118","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1038\/ng.2956","volume":"46","author":"G Goh","year":"2014","unstructured":"Goh, G. et al. Recurrent activating mutation in PRKACA in cortisol-producing adrenal tumors. Nat. Genet. 46, 613\u2013617 (2014).","journal-title":"Nat. Genet."},{"key":"491_CR119","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1126\/science.1252328","volume":"344","author":"Y Sato","year":"2014","unstructured":"Sato, Y. et al. Recurrent somatic mutations underlie corticotropin-independent Cushing\u2019s syndrome. Science 344, 917\u2013920 (2014).","journal-title":"Science"},{"key":"491_CR120","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1126\/science.1249480","volume":"344","author":"Y Cao","year":"2014","unstructured":"Cao, Y. et al. Activating hotspot L205R mutation in PRKACA and adrenal Cushing\u2019s syndrome. Science 344, 913\u2013917 (2014).","journal-title":"Science"},{"key":"491_CR121","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1056\/NEJMoa1310359","volume":"370","author":"F Beuschlein","year":"2014","unstructured":"Beuschlein, F. et al. Constitutive activation of PKA catalytic subunit in adrenal Cushing\u2019s syndrome. N. Engl. J. Med. 370, 1019\u20131028 (2014).","journal-title":"N. Engl. J. Med."},{"key":"491_CR122","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1056\/NEJMc0706182","volume":"358","author":"A Horvath","year":"2008","unstructured":"Horvath, A., Mericq, V. & Stratakis, C. A. Mutation in PDE8B, a cyclic AMP\u2013specific phosphodiesterase in adrenal hyperplasia. N. Engl. J. Med. 358, 750\u2013752 (2008).","journal-title":"N. Engl. J. Med."},{"key":"491_CR123","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1038\/79238","volume":"26","author":"LS Kirschner","year":"2000","unstructured":"Kirschner, L. S. et al. Mutations of the gene encoding the protein kinase A type I-\u03b1 regulatory subunit in patients with the Carney complex. Nat. Genet. 26, 89\u201392 (2000).","journal-title":"Nat. Genet."},{"key":"491_CR124","doi-asserted-by":"publisher","first-page":"2085","DOI":"10.1210\/jc.2008-2333","volume":"94","author":"J Bertherat","year":"2009","unstructured":"Bertherat, J. et al. Mutations in regulatory subunit type 1A of cyclic adenosine 5\u2032-monophosphate-dependent protein kinase (PRKAR1A): phenotype analysis in 353 patients and 80 different genotypes. J. Clin. Endocrinol. Metab. 94, 2085\u20132091 (2009).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"491_CR125","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pgen.1000980","volume":"6","author":"I Sahut-Barnola","year":"2010","unstructured":"Sahut-Barnola, I. et al. Cushing\u2019s syndrome and fetal features resurgence in adrenal cortex-specific Prkar1a knockout mice. PLoS Genet. 6, 1\u201316 (2010).","journal-title":"PLoS Genet."},{"key":"491_CR126","doi-asserted-by":"publisher","first-page":"3526","DOI":"10.1210\/jc.2016-1586","volume":"101","author":"CL Ronchi","year":"2016","unstructured":"Ronchi, C. L. et al. Genetic landscape of sporadic unilateral adrenocortical adenomas without PRKACA p.Leu206Arg mutation. J. Clin. Endocrinol. Metab. 101, 3526\u20133538 (2016).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"491_CR127","doi-asserted-by":"publisher","DOI":"10.1038\/srep19546","volume":"6","author":"T \u00c5kerstr\u00f6m","year":"2016","unstructured":"\u00c5kerstr\u00f6m, T. et al. Activating mutations in CTNNB1 in aldosterone producing adenomas. Sci. Rep. 6, 19546 (2016).","journal-title":"Sci. Rep."},{"key":"491_CR128","doi-asserted-by":"publisher","first-page":"E419","DOI":"10.1210\/jc.2010-1885","volume":"96","author":"S Bonnet","year":"2011","unstructured":"Bonnet, S. et al. Wnt\/\u03b2-catenin pathway activation in adrenocortical adenomas is frequently due to somatic CTNNB1-activating mutations, which are associated with larger and nonsecreting tumors: a study in cortisol-secreting and -nonsecreting tumors. J. Clin. Endocrinol. Metab. 96, E419\u2013E426 (2011).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"491_CR129","doi-asserted-by":"publisher","first-page":"3495","DOI":"10.1093\/hmg\/ddx235","volume":"26","author":"A Berthon","year":"2017","unstructured":"Berthon, A. et al. Age-dependent effects of Armc5 haploinsufficiency on adrenocortical function. Hum. Mol. Genet. 26, 3495\u20133507 (2017).","journal-title":"Hum. Mol. Genet."},{"key":"491_CR130","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.beem.2018.01.003","volume":"32","author":"M St-Jean","year":"2018","unstructured":"St-Jean, M., Ghorayeb, N. E. L., Bourdeau, I. & Lacroix, A. Aberrant G-protein coupled hormone receptor in adrenal diseases. Best Pract. Res. Clin. Endocrinol. Metab. 32, 165\u2013187 (2018).","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"key":"491_CR131","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1056\/NEJM199911183412104","volume":"341","author":"A Lacroix","year":"1999","unstructured":"Lacroix, A., Hamet, P. & Boutin, J.-M. Leuprolide acetate therapy in luteinizing hormone\u2013dependent Cushing\u2019s syndrome. N. Engl. J. Med. 341, 1577\u20131581 (1999).","journal-title":"N. Engl. J. Med."},{"key":"491_CR132","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1095\/biolreprod.104.027300","volume":"71","author":"CV Rao","year":"2004","unstructured":"Rao, C. V., Zhou, X. L. & Lei, Z. M. Functional luteinizing hormone\/chorionic gonadotropin receptors in human adrenal cortical H295R cells. Biol. Reprod. 71, 579\u2013587 (2004).","journal-title":"Biol. Reprod."},{"key":"491_CR133","first-page":"2397","volume":"81","author":"JE Pabon","year":"1996","unstructured":"Pabon, J. E. et al. Novel presence of luteinizing hormone\/chorionic gonadotropin receptors in human adrenal glands. J. Clin. Endocrinol. Metab. 81, 2397\u20132400 (1996).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"491_CR134","doi-asserted-by":"publisher","first-page":"3951","DOI":"10.1128\/MCB.23.11.3951-3964.2003","volume":"23","author":"F Beuschlein","year":"2003","unstructured":"Beuschlein, F. et al. Activin induces X-zone apoptosis that inhibits luteinizing hormone-dependent adrenocortical tumor formation in inhibin-deficient mice. Mol. Cell. Biol. 23, 3951\u20133964 (2003).","journal-title":"Mol. Cell. Biol."},{"key":"491_CR135","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1677\/joe.1.06750","volume":"190","author":"IK Johnsen","year":"2006","unstructured":"Johnsen, I. K. et al. Gonadectomy in mice of the inbred strain CE\/J induces proliferation of sub-capsular adrenal cells expressing gonadal marker genes. J. Endocrinol. 190, 47\u201357 (2006).","journal-title":"J. Endocrinol."},{"key":"491_CR136","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1159\/000481718","volume":"43","author":"M Doroszko","year":"2017","unstructured":"Doroszko, M. et al. Luteinizing hormone and GATA4 action in the adrenocortical tumorigenesis of gonadectomized female mice. Cell. Physiol. Biochem. 43, 1064\u20131076 (2017).","journal-title":"Cell. Physiol. Biochem."},{"key":"491_CR137","first-page":"1845","volume":"126","author":"M Chrusciel","year":"2013","unstructured":"Chrusciel, M. et al. Transgenic GATA-4 expression induces adrenocortical tumorigenesis in C57BL\/6 mice. J. Cell Sci. 126, 1845\u20131857 (2013).","journal-title":"J. Cell Sci."},{"key":"491_CR138","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1210\/jc.2005-1298","volume":"91","author":"K Saner-Amigh","year":"2006","unstructured":"Saner-Amigh, K. et al. Elevated expression of luteinizing hormone receptor in aldosterone- producing adenomas. J. Clin. Endocrinol. Metab. 91, 1136\u20131142 (2006).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"491_CR139","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1677\/JOE-07-0037","volume":"195","author":"P Ye","year":"2007","unstructured":"Ye, P., Mariniello, B., Mantero, F., Shibata, H. & Rainey, W. E. G-protein-coupled receptors in aldosterone-producing adenomas: a potential cause of hyperaldosteronism. J. Endocrinol. 195, 39\u201348 (2007).","journal-title":"J. Endocrinol."},{"key":"491_CR140","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1016\/j.ccell.2016.04.002","volume":"29","author":"S Zheng","year":"2016","unstructured":"Zheng, S. et al. Comprehensive pan-genomic characterization of adrenocortical carcinoma. Cancer Cell 29, 723\u2013736 (2016).","journal-title":"Cancer Cell"},{"key":"491_CR141","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1038\/ng.2953","volume":"46","author":"G Assi\u00e9","year":"2014","unstructured":"Assi\u00e9, G. et al. Integrated genomic characterization of adrenocortical carcinoma. Nat. Genet. 46, 607\u2013612 (2014).","journal-title":"Nat. Genet."},{"key":"491_CR142","doi-asserted-by":"publisher","first-page":"E493","DOI":"10.1210\/jc.2014-3282","volume":"100","author":"CC Juhlin","year":"2015","unstructured":"Juhlin, C. C. et al. Whole-exome sequencing characterizes the landscape of somatic mutations and copy number alterations in adrenocortical carcinoma. J. Clin. Endocrinol. Metab. 100, E493\u2013E502 (2015).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"491_CR143","doi-asserted-by":"publisher","first-page":"6072863","DOI":"10.1155\/2019\/6072863","volume":"2019","author":"C Fiorentini","year":"2019","unstructured":"Fiorentini, C. et al. Molecular drivers of potential immunotherapy failure in adrenocortical carcinoma. J. Oncol. 2019, 6072863 (2019).","journal-title":"J. Oncol."},{"key":"491_CR144","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1186\/s40425-019-0722-x","volume":"7","author":"MA Habra","year":"2019","unstructured":"Habra, M. A. et al. Phase II clinical trial of pembrolizumab efficacy and safety in advanced adrenocortical carcinoma. J. Immunother. Cancer 7, 253 (2019).","journal-title":"J. Immunother. Cancer"},{"key":"491_CR145","doi-asserted-by":"publisher","first-page":"33972","DOI":"10.18632\/oncotarget.15687","volume":"8","author":"S Shang","year":"2017","unstructured":"Shang, S., Hua, F. & Hu, Z. W. The regulation of \u03b2-catenin activity and function in cancer: therapeutic opportunities. Oncotarget 8, 33972\u201333989 (2017).","journal-title":"Oncotarget"},{"key":"491_CR146","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.ctrv.2017.11.002","volume":"62","author":"N Krishnamurthy","year":"2018","unstructured":"Krishnamurthy, N. & Kurzrock, R. Targeting the Wnt\/\u03b2-catenin pathway in cancer: update on effectors and inhibitors. Cancer Treat. Rev. 62, 50\u201360 (2018).","journal-title":"Cancer Treat. Rev."},{"key":"491_CR147","doi-asserted-by":"publisher","first-page":"2197","DOI":"10.1038\/onc.2015.280","volume":"35","author":"B Madan","year":"2016","unstructured":"Madan, B. et al. Wnt addiction of genetically defined cancers reversed by PORCN inhibition. Oncogene 35, 2197\u20132207 (2016).","journal-title":"Oncogene"},{"key":"491_CR148","doi-asserted-by":"publisher","first-page":"6662","DOI":"10.1038\/s41388-019-0908-1","volume":"38","author":"Z Zhong","year":"2019","unstructured":"Zhong, Z. et al. PORCN inhibition synergizes with PI3K\/mTOR inhibition in Wnt-addicted cancers. Oncogene 38, 6662\u20136677 (2019).","journal-title":"Oncogene"},{"key":"491_CR149","doi-asserted-by":"publisher","first-page":"7548","DOI":"10.1073\/pnas.1508113112","volume":"112","author":"BK Koo","year":"2015","unstructured":"Koo, B. K., Van Es, J. H., Van Den Born, M. & Clevers, H. Porcupine inhibitor suppresses paracrine Wnt-driven growth of Rnf43;Znrf3-mutant neoplasia. Proc. Natl Acad. Sci. USA 112, 7548\u20137550 (2015).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"491_CR150","doi-asserted-by":"publisher","first-page":"11717","DOI":"10.1073\/pnas.1120068109","volume":"109","author":"A Gurney","year":"2012","unstructured":"Gurney, A. et al. Wnt pathway inhibition via the targeting of Frizzled receptors results in decreased growth and tumorigenicity of human tumors. Proc. Natl Acad. Sci. USA 109, 11717\u201311722 (2012).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"491_CR151","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.1700090","volume":"3","author":"MM Fischer","year":"2017","unstructured":"Fischer, M. M. et al. WNT antagonists exhibit unique combinatorial antitumor activity with taxanes by potentiating mitotic cell death. Sci. Adv. 3, e1700090 (2017).","journal-title":"Sci. Adv."},{"key":"491_CR152","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0033976","volume":"7","author":"RM Hallett","year":"2012","unstructured":"Hallett, R. M. et al. Small molecule antagonists of the Wnt\/\u03b2-catenin signaling pathway target breast tumor-initiating cells in a Her2\/Neu mouse model of breast cancer. PLoS ONE 7, e33976 (2012).","journal-title":"PLoS ONE"},{"key":"491_CR153","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1593\/neo.91972","volume":"12","author":"RK Gandhirajan","year":"2010","unstructured":"Gandhirajan, R. K. et al. Small molecule inhibitors of Wnt\/\u03b2-Catenin\/Lef-1 signaling induces apoptosis in chronic lymphocytic leukemia cells in vitro and in vivo. Neoplasia 12, 326\u2013335 (2010).","journal-title":"Neoplasia"},{"key":"491_CR154","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1002\/prot.20955","volume":"64","author":"JY Trosset","year":"2006","unstructured":"Trosset, J. Y. et al. Inhibition of protein-protein interactions: the discovery of druglike \u03b2-catenin inhibitors by combining virtual and biophysical screening. Proteins Struct. Funct. Genet. 64, 60\u201367 (2006).","journal-title":"Proteins Struct. Funct. Genet."},{"key":"491_CR155","doi-asserted-by":"publisher","first-page":"43016","DOI":"10.18632\/oncotarget.5513","volume":"6","author":"LF Leal","year":"2015","unstructured":"Leal, L. F. et al. Inhibition of the Tcf\/\u03b2-catenin complex increases apoptosis and impairs adrenocortical tumor cell proliferation and adrenal steroidogenesis. Oncotarget 6, 43016\u201343032 (2015).","journal-title":"Oncotarget"},{"key":"491_CR156","doi-asserted-by":"publisher","first-page":"22","DOI":"10.3390\/cancers8020022","volume":"8","author":"T Rimkus","year":"2016","unstructured":"Rimkus, T., Carpenter, R., Qasem, S., Chan, M. & Lo, H.-W. Targeting the sonic hedgehog signaling pathway: review of smoothened and GLI inhibitors. Cancers 8, 22 (2016).","journal-title":"Cancers"},{"key":"491_CR157","doi-asserted-by":"publisher","first-page":"2152","DOI":"10.1016\/S0140-6736(13)61684-0","volume":"383","author":"E Charmandari","year":"2014","unstructured":"Charmandari, E., Nicolaides, N. C. & Chrousos, G. P. Adrenal insufficiency. Lancet 383, 2152\u20132167 (2014).","journal-title":"Lancet"},{"key":"491_CR158","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1038\/9629","volume":"22","author":"JC Achermann","year":"1999","unstructured":"Achermann, J. C., Ito, M., Ito, M., Hindmarsh, P. C. & Jameson, J. L. A mutation in the gene encoding steroidogenic factor-1 causes XY sex reversal and adrenal failure in humans. Nat. Genet. 22, 125\u2013126 (1999).","journal-title":"Nat. Genet."},{"key":"491_CR159","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1172\/JCI60224","volume":"122","author":"CR Hughes","year":"2012","unstructured":"Hughes, C. R. et al. MCM4 mutation causes adrenal failure, short stature, and natural killer cell deficiency in humans. J. Clin. Invest. 122, 814\u2013820 (2012).","journal-title":"J. Clin. Invest."},{"key":"491_CR160","doi-asserted-by":"publisher","first-page":"E1556","DOI":"10.1210\/jc.2013-3844","volume":"99","author":"R Prasad","year":"2014","unstructured":"Prasad, R. et al. Thioredoxin reductase 2 (TXNRD2) mutation associated with familial glucocorticoid deficiency (FGD). J. Clin. Endocrinol. Metab. 99, E1556\u2013E1563 (2014).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"491_CR161","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1038\/ng.2299","volume":"44","author":"E Meimaridou","year":"2012","unstructured":"Meimaridou, E. et al. Mutations in NNT encoding nicotinamide nucleotide transhydrogenase cause familial glucocorticoid deficiency. Nat. Genet. 44, 740\u2013742 (2012).","journal-title":"Nat. Genet."},{"key":"491_CR162","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1093\/hmg\/10.3.283","volume":"10","author":"K Handschug","year":"2001","unstructured":"Handschug, K. et al. Triple A syndrome is caused by mutations in AAAS, a new WD-repeat protein gene. Hum. Mol. Genet. 10, 283\u2013290 (2001).","journal-title":"Hum. Mol. Genet."},{"key":"491_CR163","doi-asserted-by":"publisher","first-page":"4849","DOI":"10.1210\/jc.2006-0076","volume":"91","author":"R Bergthorsdottir","year":"2006","unstructured":"Bergthorsdottir, R., Leonsson-Zachrisson, M., Od\u00e9n, A. & Johannsson, G. Premature mortality in patients with Addison\u2019s disease: a population-based study. J. Clin. Endocrinol. Metab. 91, 4849\u20134853 (2006).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"491_CR164","doi-asserted-by":"publisher","first-page":"R123","DOI":"10.1530\/EJE-16-0581","volume":"3","author":"EH Gan","year":"2017","unstructured":"Gan, E. H. & Pierce, S. H. Regenerative therapies in autoimmune Addison\u2019s disease. Eur. J. Endocrinol. 3, R123\u2013R135 (2017).","journal-title":"Eur. J. Endocrinol."},{"key":"491_CR165","doi-asserted-by":"publisher","first-page":"70","DOI":"10.3389\/fendo.2015.00070","volume":"6","author":"G Ruiz-Babot","year":"2015","unstructured":"Ruiz-Babot, G., Hadjidemetriou, I., King, P. J. & Guasti, L. New directions for the treatment of adrenal insufficiency. Front. Endocrinol. 6, 70 (2015).","journal-title":"Front. Endocrinol."},{"key":"491_CR166","doi-asserted-by":"publisher","first-page":"4336","DOI":"10.1210\/en.2012-1060","volume":"153","author":"T Sonoyama","year":"2012","unstructured":"Sonoyama, T. et al. Differentiation of human embryonic stem cells and human induced pluripotent stem cells into steroid-producing cells. Endocrinology 153, 4336\u20134345 (2012).","journal-title":"Endocrinology"},{"key":"491_CR167","doi-asserted-by":"publisher","first-page":"23274","DOI":"10.1073\/pnas.1908207116","volume":"116","author":"L Li","year":"2019","unstructured":"Li, L. et al. Directing differentiation of human induced pluripotent stem cells toward androgen-producing Leydig cells rather than adrenal cells. Proc. Natl Acad. Sci. USA 116, 23274\u201323283 (2019).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"491_CR168","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1007\/BF03345623","volume":"31","author":"LCCJ Smans","year":"2008","unstructured":"Smans, L. C. C. J. & Zelissen, P. M. J. Partial recovery of adrenal function in a patient with autoimmune Addison\u2019s disease. J. Endocrinol. Invest. 31, 672\u2013674 (2008).","journal-title":"J. Endocrinol. Invest."},{"key":"491_CR169","first-page":"130070","volume":"2013","author":"M Baxter","year":"2013","unstructured":"Baxter, M., Gorick, S. & Swords, F. M. Recovery of adrenal function in a patient with confirmed Addison\u2019s disease. Endocrinol. Diabetes Metab. Case Rep. 2013, 130070 (2013).","journal-title":"Endocrinol. Diabetes Metab. Case Rep."},{"key":"491_CR170","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1093\/qjmed\/hcr162","volume":"105","author":"AJ Chakera","year":"2012","unstructured":"Chakera, A. J. & Vaidya, B. Spontaneously resolving Addison\u2019s disease. QJM 105, 1113\u20131115 (2012).","journal-title":"QJM"},{"key":"491_CR171","doi-asserted-by":"publisher","first-page":"639","DOI":"10.3390\/cancers12030639","volume":"12","author":"J Poirier","year":"2020","unstructured":"Poirier, J. et al. Recovery of adrenal insufficiency is frequent after adjuvant mitotane therapy in patients with adrenocortical carcinoma. Cancers 12, 639 (2020).","journal-title":"Cancers"},{"key":"491_CR172","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1111\/j.1365-2265.2011.04276.x","volume":"76","author":"PR Baker","year":"2012","unstructured":"Baker, P. R. et al. Predicting the onset of Addison\u2019s disease: ACTH, renin, cortisol and 21-hydroxylase autoantibodies. Clin. Endocrinol. 76, 617\u2013624 (2012).","journal-title":"Clin. Endocrinol."},{"key":"491_CR173","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1038\/nrendo.2010.235","volume":"7","author":"M Fassnacht","year":"2011","unstructured":"Fassnacht, M., Lib\u00e9, R., Kroiss, M. & Allolio, B. Adrenocortical carcinoma: a clinician\u2019s update. Nat. Rev. Endocrinol. 7, 323\u2013335 (2011).","journal-title":"Nat. Rev. Endocrinol."},{"key":"491_CR174","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1056\/NEJM199004263221705","volume":"322","author":"JP Luton","year":"1990","unstructured":"Luton, J. P. et al. Clinical features of adrenocortical carcinoma, prognostic factors, and the effect of mitotane therapy. N. Engl. J. Med. 322, 1195\u20131201 (1990).","journal-title":"N. Engl. J. Med."},{"key":"491_CR175","first-page":"117","volume":"86","author":"J Lindholm","year":"2001","unstructured":"Lindholm, J. et al. Incidence and late prognosis of Cushing\u2019s syndrome: a population-based study 1. J. Clin. Endocrinol. Metab. 86, 117\u2013123 (2001).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"491_CR176","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000314297","volume":"92","author":"C Steffensen","year":"2010","unstructured":"Steffensen, C., Bak, A. M., Z\u00f8ylner Rubeck, K. & J\u00f8rgensen, J. O. L. Epidemiology of Cushing\u2019s syndrome. Neuroendocrinology 92, 1\u20135 (2010).","journal-title":"Neuroendocrinology"},{"key":"491_CR177","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1159\/000134829","volume":"13","author":"C Stratakis","year":"2008","unstructured":"Stratakis, C. Cushing syndrome caused by adrenocortical tumors and hyperplasias (corticotropin-independent Cushing syndrome). Endocr. Dev. 13, 117\u2013132 (2008).","journal-title":"Endocr. Dev."},{"key":"491_CR178","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1111\/j.1365-2265.1994.tb02790.x","volume":"41","author":"M-F Kong","year":"1994","unstructured":"Kong, M.-F. & Jeffcoate, W. Eighty-six cases of Addison\u2019s disease. Clin. Endocrinol. 41, 757\u2013761 (1994).","journal-title":"Clin. Endocrinol."},{"key":"491_CR179","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1210\/jcem.87.2.8192","volume":"87","author":"AG Myhre","year":"2002","unstructured":"Myhre, A. G. et al. Autoimmune adrenocortical failure in norway autoantibodies and human leukocyte antigen class II associations related to clinical features. J. Clin. Endocrinol. Metab. 87, 618\u2013623 (2002).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"491_CR180","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1016\/j.ajpath.2012.05.026","volume":"181","author":"JH Heaton","year":"2012","unstructured":"Heaton, J. H. et al. Progression to adrenocortical tumorigenesis in mice and humans through insulin-like growth factor 2 and \u03b2-catenin. Am. J. Pathol. 181, 1017\u20131033 (2012).","journal-title":"Am. J. Pathol."},{"key":"491_CR181","doi-asserted-by":"publisher","first-page":"2215","DOI":"10.1210\/en.2019-00357","volume":"160","author":"WC Engeland","year":"2019","unstructured":"Engeland, W. C. et al. Sex differences in adrenal Bmal1 deletion-induced augmentation of glucocorticoid responses to stress and ACTH in mice. Endocrinology 160, 2215\u20132229 (2019).","journal-title":"Endocrinology"},{"key":"491_CR182","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.mce.2008.10.045","volume":"300","author":"S Lambert-Langlais","year":"2009","unstructured":"Lambert-Langlais, S. et al. A transgenic mouse line with specific Cre recombinase expression in the adrenal cortex. Mol. Cell. Endocrinol. 300, 197\u2013204 (2009).","journal-title":"Mol. Cell. Endocrinol."},{"key":"491_CR183","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.ajhg.2007.08.005","volume":"82","author":"H Mandel","year":"2008","unstructured":"Mandel, H. et al. SERKAL syndrome: an autosomal-recessive disorder caused by a loss-of-function mutation in WNT4. Am. J. Hum. Genet. 82, 39\u201347 (2008).","journal-title":"Am. J. Hum. Genet."},{"key":"491_CR184","doi-asserted-by":"publisher","first-page":"4358","DOI":"10.1210\/en.2002-220275","volume":"143","author":"M Heikkil\u00e4","year":"2002","unstructured":"Heikkil\u00e4, M. et al. Wnt-4 deficiency alters mouse adrenal cortex function, reducing aldosterone production. Endocrinology 143, 4358\u20134365 (2002).","journal-title":"Endocrinology"}],"container-title":["Nature Reviews Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41574-021-00491-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41574-021-00491-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41574-021-00491-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,31]],"date-time":"2024-08-31T01:36:23Z","timestamp":1725068183000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41574-021-00491-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,19]]},"references-count":184,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["491"],"URL":"https:\/\/doi.org\/10.1038\/s41574-021-00491-4","relation":{},"ISSN":["1759-5029","1759-5037"],"issn-type":[{"value":"1759-5029","type":"print"},{"value":"1759-5037","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,19]]},"assertion":[{"value":"30 March 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}